Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Calcitonin (salmon) 100units/1ml inj ampoules
0606010T0AAAAAA
|
Calcitonin (Salmon) | Calcitonin (Salmon) | Endocrine System | 8 |
|
Calcitonin (salmon) 200units/dose nasal spray
0606010T0AAAGAG
|
Calcitonin (Salmon) | Calcitonin (Salmon) | Endocrine System | No data available |
|
Calcitonin (salmon) 400units/2ml inj vials
0606010T0AAABAB
|
Calcitonin (Salmon) | Calcitonin (Salmon) | Endocrine System | No data available |
|
Calcitonin (salmon) 50units/1ml inj ampoules
0606010T0AAACAC
|
Calcitonin (Salmon) | Calcitonin (Salmon) | Endocrine System | No data available |
|
Calsynar 100units/1ml solution for injection ampoules
0606010T0BBAAAA
|
Calsynar | Calcitonin (Salmon) | Endocrine System | No data available |
|
Calsynar 400units/2ml solution for injection vials
0606010T0BBABAB
|
Calsynar | Calcitonin (Salmon) | Endocrine System | No data available |
|
Miacalcic 100units/1ml solution for injection ampoules
0606010T0BCABAA
|
Miacalcic | Calcitonin (Salmon) | Endocrine System | No data available |
|
Miacalcic 200units/dose nasal spray
0606010T0BCAFAG
|
Miacalcic | Calcitonin (Salmon) | Endocrine System | No data available |
|
Miacalcic 400units/2ml multidose inj vials
0606010T0BCACAB
|
Miacalcic | Calcitonin (Salmon) | Endocrine System | No data available |
|
Miacalcic 50units/1ml solution for injection ampoules
0606010T0BCAAAC
|
Miacalcic | Calcitonin (Salmon) | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.